![]() |
Trials |
The stop-GIST-trial: Discontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor that has become radiologically undetectable with treatment. A prospective multicenter phase II trialCancer type: Gastric cancer Phase: II Principal Investigator: Joensuu Heikki Country: FI Keywords: Finland, Helsinki Status: Open for inclusion |